{
"NDC": {
"NDCCode": "45802-578-24",
"PackageDescription": "24 VIAL, SINGLE-DOSE in 1 CARTON (45802-578-24) / .1 mL in 1 VIAL, SINGLE-DOSE (45802-578-00) ",
"NDC11Code": "45802-0578-24",
"ProductNDC": "45802-578",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Naloxone Hydrochloride",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Naloxone Hydrochloride",
"DosageFormName": "SPRAY",
"RouteName": "NASAL",
"StartMarketingDate": "20230730",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA211951",
"LabelerName": "Padagis Israel Pharmaceuticals Ltd",
"SubstanceName": "NALOXONE HYDROCHLORIDE",
"StrengthNumber": "4",
"StrengthUnit": "mg/.1mL",
"Pharm_Classes": "Opioid Antagonist [EPC], Opioid Antagonists [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-01-22",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20250801",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}